Elizabeth Franzmann

Development of an Effective, Low-Cost, Point-of-Care Early Detection Test for Oral Cancer in Low Resource Settings

National Cancer Institute · R44

Contact PI · $2M · Vigilant Laboratories Llc

Aptamer Specific for Myeloid Derived Suppressor Cells for the Diagnosis of Head and Neck Cancer from the Oral Rinse

National Institute of Dental and Craniofacial Research · R21

PI · $422.1K · University of Miami School of Medicine

A Novel Point of Care Test for Oral and Oropharyngeal Cancer Risk

National Cancer Institute · R01

PI · $2.7M · University of California, San Diego

Optical Imaging of a CD44-Based Oral-Rinse with Fluorescent Detection to Visualize Oral Cancer

National Institute of Dental and Craniofacial Research · R43

Contact PI · $219.5K · Vigilant Biosciences, Inc.

A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Principal investigator · Recruiting · Phase 2

Elizabeth J Franzmann

Safety and Efficacy of APG-157 in Head and Neck Cancer

Principal investigator · Active not recruiting · Phase 2

Aveta Biomics, Inc.